Inibição sistêmica da NADPH oxidase: estudo do coração de ratos espontaneamente hipertensos com diabetes mellitus

Detalhes bibliográficos
Autor(a) principal: Bassetto, Camila Moreno Rosa [UNESP]
Data de Publicação: 2015
Tipo de documento: Tese
Idioma: por
Título da fonte: Repositório Institucional da UNESP
Texto Completo: http://hdl.handle.net/11449/139331
http://www.athena.biblioteca.unesp.br/exlibris/bd/cathedra/06-06-2016/000865881.pdf
Resumo: Cardiovascular diseases (CVD) are the major cause of morbidity and mortality worldwide. Diabetes mellitus (DM) and arterial hypertension (AH) are the main risk factors for the development of CVD. The coexistence of diabetes and hypertension is common and leads to an increased risk of cardiovascular events. Organs damage caused by hypertension and DM have been associated with increased oxidative stress. Nicotinamide adenine dinucleotide phosphate (NADPH) oxidase enzymes family is a major source of reactive oxygen species in the cardiovascular system. Apocynin (APO) has been characterized as an inhibitor of NADPH oxidase since the 1980's decade. Despite promising evidence of APO in the treatment of many diseases, there are studies questioning its power as an inhibitor of NADPH oxidase. Besides controversies on the use of apocynin in blocking NADPH oxidase in non-phagocytic cells, few studies have evaluated the effects of its blockade on cardiac remodeling. In addition, there is a lack of information when AH and DM are associated. Therefore, the aim was to analyze the influence of NADPH oxidase inhibition by apocynin on cardiac remodeling in spontaneously hypertensive rats (SHR) with diabetes mellitus. Methods: Seven-month-old male SHR were divided into four groups: control (CTL, n=18); CTL+APO (n=18); DM (n=20); DM+APO (n=20). DM was induced by streptozotocin (40 mg/kg, i.p., single dose). CTL+APO and DM+APO groups received APO (16 mg/kg/day, diluted in the water) for 8 weeks. In vivo cardiac structures and functions were assessed by echocardiogram. In vitro functional study was performed by left ventricular papillary muscle study. In vitro left ventricle (LV), right ventricle and atria weights were measured. Samples of these structures, liver and lung were used to calculate the wet/dry weight ratio. LV tissue samples were obtained to measure myocyte diameters, interstitial collagen fraction, and hydroxyproline concentration. Left ...
id UNSP_3a4a015958a0813a4c937891710151ce
oai_identifier_str oai:repositorio.unesp.br:11449/139331
network_acronym_str UNSP
network_name_str Repositório Institucional da UNESP
repository_id_str 2946
spelling Inibição sistêmica da NADPH oxidase: estudo do coração de ratos espontaneamente hipertensos com diabetes mellitusDiabetes mellitusHipertensãoStress oxidativoNADPH OxidaseHypertensionCardiovascular diseases (CVD) are the major cause of morbidity and mortality worldwide. Diabetes mellitus (DM) and arterial hypertension (AH) are the main risk factors for the development of CVD. The coexistence of diabetes and hypertension is common and leads to an increased risk of cardiovascular events. Organs damage caused by hypertension and DM have been associated with increased oxidative stress. Nicotinamide adenine dinucleotide phosphate (NADPH) oxidase enzymes family is a major source of reactive oxygen species in the cardiovascular system. Apocynin (APO) has been characterized as an inhibitor of NADPH oxidase since the 1980's decade. Despite promising evidence of APO in the treatment of many diseases, there are studies questioning its power as an inhibitor of NADPH oxidase. Besides controversies on the use of apocynin in blocking NADPH oxidase in non-phagocytic cells, few studies have evaluated the effects of its blockade on cardiac remodeling. In addition, there is a lack of information when AH and DM are associated. Therefore, the aim was to analyze the influence of NADPH oxidase inhibition by apocynin on cardiac remodeling in spontaneously hypertensive rats (SHR) with diabetes mellitus. Methods: Seven-month-old male SHR were divided into four groups: control (CTL, n=18); CTL+APO (n=18); DM (n=20); DM+APO (n=20). DM was induced by streptozotocin (40 mg/kg, i.p., single dose). CTL+APO and DM+APO groups received APO (16 mg/kg/day, diluted in the water) for 8 weeks. In vivo cardiac structures and functions were assessed by echocardiogram. In vitro functional study was performed by left ventricular papillary muscle study. In vitro left ventricle (LV), right ventricle and atria weights were measured. Samples of these structures, liver and lung were used to calculate the wet/dry weight ratio. LV tissue samples were obtained to measure myocyte diameters, interstitial collagen fraction, and hydroxyproline concentration. Left ...As doenças cardiovasculares (DCV) são a maior causa de invalidez e mortalidade em todo o mundo. Entre os principais fatores de risco para o desenvolvimento das DCV estão o diabetes mellitus (DM) e a hipertensão arterial sistêmica (HAS). Frequentemente, há co-existência de DM e HAS e isso ocasiona aumento do risco de eventos cardiovasculares. Os danos causados tanto pela HAS como pelo DM têm sido associados com o aumento do estresse oxidativo. A família de enzimas nicotinamida adenina dinucleotídeo fosfato (NADPH) oxidase constitui uma das principais fontes de produção de espécies reativas de oxigênio no sistema cardiovascular. A apocinina (APO) tem sido caracterizada como um inibidor da NADPH oxidase desde a década de 1980. Apesar de evidências promissoras do uso da APO no tratamento de inúmeras doenças, há estudos questionando seu poder inibidor da NADPH oxidase. Além de controvérsias do uso da APO no bloqueio da NADPH oxidase em células não fagocíticas, poucos estudos avaliaram os efeitos desse bloqueio sobre o remodelamento cardíaco. Além disso, a escassez de informações é maior quando se associa HAS e DM. Portanto, o objetivo foi analisar a influência da inibição da NADPH oxidase por apocinina sobre o remodelamento cardíaco em ratos espontaneamente hipertensos (SHR) com diabetes mellitus. Métodos: SHR, machos, com 7 meses de idade, foram divididos em quatro grupos: controle (CTL, n=18), controle+apocinina (CTL+APO, n=18); diabético (DM, n=20) e diabético+apocinina (DM+APO, n=20). DM foi induzido por estreptozotocina (40 mg/kg, ip, dose única). Os grupos CTL+APO e DM+APO receberam APO (16 mg/kg/dia, diluída na água dos animais) durante 8 semanas. A avaliação estrutural e funcional in vivo do coração foi realizada por meio do ecocardiograma. O estudo funcional in vitro foi realizado pela técnica do músculo papilar do ventrículo esquerdo (VE). Para análise estrutural in vitro, foram medidos os...Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)Universidade Estadual Paulista (Unesp)Okoshi, Katashi [UNESP]Universidade Estadual Paulista (Unesp)Bassetto, Camila Moreno Rosa [UNESP]2016-06-07T17:12:08Z2016-06-07T17:12:08Z2015-02-26info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/doctoralThesis62 f.application/pdfBASSETTO, Camila Moreno Rosa. Inibição sistêmica da NADPH oxidase: estudo do coração de ratos espontaneamente hipertensos com diabetes mellitus. 2015. 62 f. Tese (doutorado) - Universidade Estadual Paulista Júlio de Mesquita Filho, Faculdade de Medicina de Botucatu, 2015.http://hdl.handle.net/11449/139331000865881http://www.athena.biblioteca.unesp.br/exlibris/bd/cathedra/06-06-2016/000865881.pdf33004064020P01590971576309420Alephreponame:Repositório Institucional da UNESPinstname:Universidade Estadual Paulista (UNESP)instacron:UNESPporinfo:eu-repo/semantics/openAccess2024-09-03T17:26:42Zoai:repositorio.unesp.br:11449/139331Repositório InstitucionalPUBhttp://repositorio.unesp.br/oai/requestrepositoriounesp@unesp.bropendoar:29462024-09-03T17:26:42Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)false
dc.title.none.fl_str_mv Inibição sistêmica da NADPH oxidase: estudo do coração de ratos espontaneamente hipertensos com diabetes mellitus
title Inibição sistêmica da NADPH oxidase: estudo do coração de ratos espontaneamente hipertensos com diabetes mellitus
spellingShingle Inibição sistêmica da NADPH oxidase: estudo do coração de ratos espontaneamente hipertensos com diabetes mellitus
Bassetto, Camila Moreno Rosa [UNESP]
Diabetes mellitus
Hipertensão
Stress oxidativo
NADPH Oxidase
Hypertension
title_short Inibição sistêmica da NADPH oxidase: estudo do coração de ratos espontaneamente hipertensos com diabetes mellitus
title_full Inibição sistêmica da NADPH oxidase: estudo do coração de ratos espontaneamente hipertensos com diabetes mellitus
title_fullStr Inibição sistêmica da NADPH oxidase: estudo do coração de ratos espontaneamente hipertensos com diabetes mellitus
title_full_unstemmed Inibição sistêmica da NADPH oxidase: estudo do coração de ratos espontaneamente hipertensos com diabetes mellitus
title_sort Inibição sistêmica da NADPH oxidase: estudo do coração de ratos espontaneamente hipertensos com diabetes mellitus
author Bassetto, Camila Moreno Rosa [UNESP]
author_facet Bassetto, Camila Moreno Rosa [UNESP]
author_role author
dc.contributor.none.fl_str_mv Okoshi, Katashi [UNESP]
Universidade Estadual Paulista (Unesp)
dc.contributor.author.fl_str_mv Bassetto, Camila Moreno Rosa [UNESP]
dc.subject.por.fl_str_mv Diabetes mellitus
Hipertensão
Stress oxidativo
NADPH Oxidase
Hypertension
topic Diabetes mellitus
Hipertensão
Stress oxidativo
NADPH Oxidase
Hypertension
description Cardiovascular diseases (CVD) are the major cause of morbidity and mortality worldwide. Diabetes mellitus (DM) and arterial hypertension (AH) are the main risk factors for the development of CVD. The coexistence of diabetes and hypertension is common and leads to an increased risk of cardiovascular events. Organs damage caused by hypertension and DM have been associated with increased oxidative stress. Nicotinamide adenine dinucleotide phosphate (NADPH) oxidase enzymes family is a major source of reactive oxygen species in the cardiovascular system. Apocynin (APO) has been characterized as an inhibitor of NADPH oxidase since the 1980's decade. Despite promising evidence of APO in the treatment of many diseases, there are studies questioning its power as an inhibitor of NADPH oxidase. Besides controversies on the use of apocynin in blocking NADPH oxidase in non-phagocytic cells, few studies have evaluated the effects of its blockade on cardiac remodeling. In addition, there is a lack of information when AH and DM are associated. Therefore, the aim was to analyze the influence of NADPH oxidase inhibition by apocynin on cardiac remodeling in spontaneously hypertensive rats (SHR) with diabetes mellitus. Methods: Seven-month-old male SHR were divided into four groups: control (CTL, n=18); CTL+APO (n=18); DM (n=20); DM+APO (n=20). DM was induced by streptozotocin (40 mg/kg, i.p., single dose). CTL+APO and DM+APO groups received APO (16 mg/kg/day, diluted in the water) for 8 weeks. In vivo cardiac structures and functions were assessed by echocardiogram. In vitro functional study was performed by left ventricular papillary muscle study. In vitro left ventricle (LV), right ventricle and atria weights were measured. Samples of these structures, liver and lung were used to calculate the wet/dry weight ratio. LV tissue samples were obtained to measure myocyte diameters, interstitial collagen fraction, and hydroxyproline concentration. Left ...
publishDate 2015
dc.date.none.fl_str_mv 2015-02-26
2016-06-07T17:12:08Z
2016-06-07T17:12:08Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/doctoralThesis
format doctoralThesis
status_str publishedVersion
dc.identifier.uri.fl_str_mv BASSETTO, Camila Moreno Rosa. Inibição sistêmica da NADPH oxidase: estudo do coração de ratos espontaneamente hipertensos com diabetes mellitus. 2015. 62 f. Tese (doutorado) - Universidade Estadual Paulista Júlio de Mesquita Filho, Faculdade de Medicina de Botucatu, 2015.
http://hdl.handle.net/11449/139331
000865881
http://www.athena.biblioteca.unesp.br/exlibris/bd/cathedra/06-06-2016/000865881.pdf
33004064020P0
1590971576309420
identifier_str_mv BASSETTO, Camila Moreno Rosa. Inibição sistêmica da NADPH oxidase: estudo do coração de ratos espontaneamente hipertensos com diabetes mellitus. 2015. 62 f. Tese (doutorado) - Universidade Estadual Paulista Júlio de Mesquita Filho, Faculdade de Medicina de Botucatu, 2015.
000865881
33004064020P0
1590971576309420
url http://hdl.handle.net/11449/139331
http://www.athena.biblioteca.unesp.br/exlibris/bd/cathedra/06-06-2016/000865881.pdf
dc.language.iso.fl_str_mv por
language por
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 62 f.
application/pdf
dc.publisher.none.fl_str_mv Universidade Estadual Paulista (Unesp)
publisher.none.fl_str_mv Universidade Estadual Paulista (Unesp)
dc.source.none.fl_str_mv Aleph
reponame:Repositório Institucional da UNESP
instname:Universidade Estadual Paulista (UNESP)
instacron:UNESP
instname_str Universidade Estadual Paulista (UNESP)
instacron_str UNESP
institution UNESP
reponame_str Repositório Institucional da UNESP
collection Repositório Institucional da UNESP
repository.name.fl_str_mv Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)
repository.mail.fl_str_mv repositoriounesp@unesp.br
_version_ 1810021356532662272